BCL2 and myeloid leukemia: Etoposide treatment also caused a significant decrease of the anti-apoptotic factor BCL2 gene expression and protein levels in THP-1 myeloid leukaemia cells, when compared to the vehicle control (P ≤ 0.05) (Table 1).